Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AT(1) receptor antagonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 84 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McGill, JB
      Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone

      BLOOD PRESSURE MONITORING
    2. Littlejohn, TW
      Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic

      BLOOD PRESSURE MONITORING
    3. Lacourciere, Y
      Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone

      BLOOD PRESSURE MONITORING
    4. Lacourciere, Y; Tytus, R; O'Keefe, D; Lenis, J; Orchard, R; Martin, K
      Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

      JOURNAL OF HUMAN HYPERTENSION
    5. Blezer, ELA; Nicolay, K; Koomans, HA; Joles, JA
      Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats

      AMERICAN JOURNAL OF HYPERTENSION
    6. Inada, Y; Tazawa, S; Murakami, M; Akahane, M
      KRH-594, a new angiotensin AT(1) receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    7. Paull, JRA; Widdop, RE
      Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats

      JOURNAL OF HYPERTENSION
    8. Watanabe, T; Pakala, R; Katagiri, T; Benedict, CR
      Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation

      JOURNAL OF HYPERTENSION
    9. Fukuhara, M; Neves, LA; Li, P; Diz, DI; Ferrario, CM; Brosnihan, KB
      The angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in the rat hind-limb vascular bed in vivo

      JOURNAL OF HYPERTENSION
    10. van Kats, JP; van Meegen, JR; Verdouw, PD; Duncker, DJ; Schalekamp, MADH; Danser, AHJ
      Subcellular localization of angiotensin II in kidney and adrenal

      JOURNAL OF HYPERTENSION
    11. McGill, JB; Reilly, PA
      Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

      CLINICAL CARDIOLOGY
    12. Stangier, J; Su, CAPF; van Heiningen, PNM; Meinicke, T; van Lier, JJ; de Bruin, H; Tamminga, WJ; Jonkman, JHG
      Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    13. Takata, Y; Kurihara, J; Yoda, T; Suzuki, S; Matsuoka, Y; Okubo, Y; Kato, H
      KT3-671, an angiotensin AT(1) receptor antagonist, attenuates vascular butnot cardiac responses to sympathetic nerve stimulation in pithed rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    14. Girard, A; Holand, S; Laude, D; Elghozi, JL
      Antihypertensive monotherapy and cardiovascular responses to an acoustic startle stimulus

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    15. McGill, JB; Reilly, PA
      Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

      CLINICAL THERAPEUTICS
    16. Tokioka-Akagi, T; Fujimori, A; Shibasaki, M; Inagaki, O; Yanagisawa, I
      Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload

      JAPANESE JOURNAL OF PHARMACOLOGY
    17. Breno, MC; Porto, CS; Picarelli, ZP
      Angiotensin receptor in the heart of Bothrops jararaca snake

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Sharpe, M; Jarvis, B; Goa, KL
      Telmisartan - A review of its use in hypertension

      DRUGS
    19. Yang, XP; Liu, YH; Mehta, D; Cavasin, MA; Shesely, E; Xu, J; Liu, F; Carretero, OA
      Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B-2 kinin receptor gene knockout mice

      CIRCULATION RESEARCH
    20. Tonkon, M; Awan, N; Niazi, I; Hanley, P; Baruch, L; Wolf, RA; Block, AJ
      A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    21. Takata, Y; Tajima, S; Kato, H
      Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptorantagonist, on sympathetic neurotransmission in isolated rabbit aorta

      PHARMACOLOGICAL RESEARCH
    22. Mallion, JM; Baguet, JP
      Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data

      JOURNAL OF HUMAN HYPERTENSION
    23. Inada, Y; Murakami, M; Tazawa, S; Akahane, M
      KRH-594, a new angiotensin AT(1) receptor antagonist, ameliorates nephropathy and hyperlipidaemia in diabetic spontaneously hypertensive rats

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    24. Stangier, J; Su, CAPF; Roth, W
      Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    25. Yong, CL; Dias, VC; Stangier, J
      Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    26. Smith, DHG; Matzek, KM; Kempthorne-Rawson, J
      Dose response and safety of telmisartan in patients with mild to moderate hypertension

      JOURNAL OF CLINICAL PHARMACOLOGY
    27. Davi, H; Tronquet, C; Miscoria, G; Perrier, L; Dupont, P; Caix, J; Simiand, J; Berger, Y
      Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques

      DRUG METABOLISM AND DISPOSITION
    28. Bidani, AK; Griffin, KA; Bakris, G; Picken, MM
      Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation

      KIDNEY INTERNATIONAL
    29. Verhagen, AMG; Hohbach, J; Joles, JA; Braam, B; Boer, P; Koomans, HA; Grone, HJ
      Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition

      EUROPEAN JOURNAL OF PHARMACOLOGY
    30. Houghton, AR; Harrison, M; Cowley, AJ
      Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy

      EUROPEAN JOURNAL OF HEART FAILURE
    31. Sever, PS
      Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists

      JOURNAL OF HUMAN HYPERTENSION
    32. Hashimoto, Y; Yabana, H; Narita, H
      Diverse effects of AT(1) receptor antagonists on normal blood pressure andregulatory system

      Hypertension research
    33. Hope, S; Brecher, P; Chobanian, AV
      Comparison of the effects of AT(1) receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis

      AMERICAN JOURNAL OF HYPERTENSION
    34. Dukacz, SAW; Kline, RL
      Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.

      JOURNAL OF HYPERTENSION
    35. Karlberg, BE; Lins, LE; Hermansson, K
      Efficacy and safety of telmisartan, a selective AT(1) receptor antagonist,compared with enalapril in elderly patients with primary hypertension

      JOURNAL OF HYPERTENSION
    36. Blais, C; Leclair, P; Molinaro, G; Adam, A
      Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations in the carrageenan-induced paw edema model inthe rat

      PEPTIDES
    37. Faggiotto, A; Paoletti, R
      Statins and blockers of the renin-angiotensin system - Vascular protectionbeyond their primary mode of action

      HYPERTENSION
    38. Ebisu, H; Nishikawa, M; Tanaka, M; Okazoe, T; Morizawa, Y; Shinyama, H; Nakamura, N
      Pharmacologic profiles of CA0113, a novel quinoline derivative angiotensinII AT(1)-receptor antagonist

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    39. Kurosawa, Y; Minami, K; Hashimoto, Y; Narita, H
      Functional and binding studies of insurmountable antagonism of 606A, a novel AT(1)-receptor antagonist in rabbit tissues

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    40. Lee, SH; Jung, YS; Lee, BH; Yun, SI; Yoo, SE; Shin, HS
      Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT(1)-receptor antagonist

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    41. Lee, BH; Seo, HW; Kwon, KJ; Yoo, SE; Shin, HS
      In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT(1)-receptor antagonist

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    42. Wang, J; Yi, GH; Zhu, SM; Gu, AG; Popilskis, S; Zhang, H; Burkhoff, D
      The role of angiotensin II AT(1) receptor in the maintenance of hemodynamics in a canine model of coronary microembolization-induced heart failure

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    43. Miyazaki, M; Shiota, N; Sakonjo, H; Takai, S
      Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog

      JAPANESE JOURNAL OF PHARMACOLOGY
    44. Xia, QG; Chung, O; Spitznagel, H; Sandmann, S; Illner, S; Rossius, B; Jahnichen, G; Reinecke, A; Gohlke, P; Unger, T
      Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. Nagamatsu, T; Hayashi, K; Oka, T; Suzuki, Y
      Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Baan, J
      AT(1)-receptor antagonists for the treatment of chronic heart failure

      CARDIOVASCULAR RESEARCH
    47. COHEN A; BREGMAN B; ROSEI EA; WILLIAMS B; DUBOURG O; CLAIREFOND P; BRUDI P; GOSSE P; GUERET P
      COMPARISON OF IRBESARTAN VS FELODIPINE IN THE REGRESSION AFTER 1 YEAROF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS (THE SILVER TRIAL)

      Journal of human hypertension
    48. Mitsunami, K; Inoue, S; Maeda, K; Endoh, S; Takahashi, M; Okada, M; Sugihara, H; Kinoshita, M
      Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT(1)) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension

      CARDIOVASCULAR DRUGS AND THERAPY
    49. WEBB RL; NAVARRETE AE; DAVIS S
      EFFECTS OF VALSARTAN AND HYDROCHLOROTHIAZIDE ALONE AND IN COMBINATIONON BLOOD-PRESSURE AND HEART-RATE IN CONSCIOUS-TELEMETERED SPONTANEOUSLY HYPERTENSIVE RATS (SHR)

      American journal of hypertension
    50. GOHLKE P; PEES C; UNGER T
      AT(2) RECEPTOR STIMULATION INCREASES AORTIC CYCLIC-GMP IN SHRSP BY A KININ-DEPENDENT MECHANISM

      Hypertension
    51. MORIUCHI R; SHIBATA S; HIMENO A; JOHREN O; HOE KL; SAAVEDRA JM
      MOLECULAR-CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF AN ATYPICALGERBIL ANGIOTENSIN-II TYPE-1 RECEPTOR AND ITS MESSENGER-RNA EXPRESSION IN BRAIN AND PERIPHERAL-TISSUES

      Molecular brain research
    52. TAKATA Y; TAJIMA S; MOCHIZUKI S; SUZAKA H; TOMIYAMA A; KATO H
      ANTIHYPERTENSIVE ACTIVITY AND PHARMACOKINETICS OF KD3-671, A NONPEPTIDE AT(1)-RECEPTOR ANTAGONIST, IN RENAL HYPERTENSIVE DOGS

      Journal of cardiovascular pharmacology
    53. DOGGRELL SA; BROWN L
      RAT MODELS OF HYPERTENSION, CARDIAC-HYPERTROPHY AND FAILURE

      Cardiovascular Research
    54. WATANABE A; ENDOH M
      RELATIONSHIP BETWEEN THE INCREASE IN CA2-FORCE INDUCED BY ANGIOTENSIN-II IN AEQUORIN-LOADED RABBIT VENTRICULAR MYOCARDIUM( TRANSIENT AND CONTRACTILE)

      Cardiovascular Research
    55. MCMAHON EG; YANG PC; BABLER MA; SULEYMANOV OD; PALOMO MA; OLINS GM; COOK CS
      EFFECTS OF SC-52458, AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST, IN THEDOG

      American journal of hypertension
    56. LANGAUERMERRMER S; BIRCHER AJ
      HYPERSENSITIVITY REACTIONS TO ACE-INHIBIT ORS

      Allergologie
    57. WRIGHT JW; HARDING JW
      IMPORTANT ROLES FOR ANGIOTENSIN-III AND ANGIOTENSIN-IV IN THE BRAIN RENIN-ANGIOTENSIN SYSTEM

      Brain research reviews
    58. SCHILLER PI; MESSMER SL; HAEFELI WE; SCHLIENGER RG; BIRCHER AJ
      ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA - LATE-ONSET, IRREGULAR COURSE, AND POTENTIAL ROLE OF TRIGGERS

      Allergy
    59. MULLER P; FLESCH G; DEGASPARO M; GASPARINI M; HOWALD H
      PHARMACOKINETICS AND PHARMACODYNAMIC EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST VALSARTAN AT STEADY-STATE IN HEALTHY, NORMOTENSIVE SUBJECTS

      European Journal of Clinical Pharmacology
    60. YAMAGUCHI N; FUJIMOTO K; FUJII T; SUZUKI T; KAWASHIMA K
      ANTIHYPERTENSIVE EFFECT OF REPEATEDLY ADMINISTERED YM358, AN ANGIOTENSIN AT(1)-RECEPTOR ANTAGONIST, IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Japanese Journal of Pharmacology
    61. SHIBASAKI M; FUJIMORI A; TAKANASHI M; KUSAYAMA T; TOKIOKA T; SATOH Y; OKAZAKI T; UCHIDA W; INAGAKI O; YANAGISAWA I
      PHARMACOLOGICAL PROFILE OF YM358, A NOVEL NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST

      European journal of pharmacology
    62. CHOW L; DEGASPARO M; LEVENS N
      BLOCKADE OF ANGIOTENSIN-CONVERTING ENZYME BUT NOT OF ANGIOTENSIN AT(1) RECEPTORS IMPROVES GLUCOSE-TOLERANCE

      European journal of pharmacology
    63. HEINEMANN A; WACHTER CH; PESKAR BA; HOLZER P
      DILATATION BY ANGIOTENSIN-II OF THE RAT FEMORAL ARTERIAL BED IN-VIVO VIA PRESSURE FLOW-INDUCED RELEASE OF NITRIC-OXIDE AND PROSTAGLANDINS/

      British Journal of Pharmacology
    64. LEDINGHAM JM; LAVERTY R
      REMODELING OF RESISTANCE ARTERIES IN GENETICALLY HYPERTENSIVE RATS BYTREATMENT WITH VALSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST

      Clinical and experimental pharmacology and physiology
    65. SUGIMOTO K; GOTOH E; TAKASAKI I; EBINA T; IWAMOTO T; TAKIZAWA T; SHIONOIRI H; ISHII M
      AT(1) RECEPTOR ANTAGONIST, TCV-116, DOES NOT PREVENT CARDIAC-HYPERTROPHY IN SALT-LOADED DAHL SALT-SENSITIVE RATS

      Clinical and experimental pharmacology and physiology
    66. NAGURA J; YAMAMOTO M; HUI C; YASUDA S; HACHISU M; KONNO F
      PROTECTIVE EFFECTS OF ME3221 ON HYPERTENSIVE COMPLICATIONS AND LIFE-SPAN IN SALT-LOADED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Clinical and experimental pharmacology and physiology
    67. KAWASHIMA K; AMANO H; FUJIMOTO K; SUZUKI T; FUJII T; MOCHIZUKI S; TOMIYAMA A
      EFFECT OF REPEATED ADMINISTRATION OF KT3-671, A NONPEPTIDE AT(1) RECEPTOR ANTAGONIST, ON DIURNAL-VARIATION IN BLOOD-PRESSURE, HEART-RATE, AND LOCOMOTOR-ACTIVITY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS AS DETERMINED BY RADIOTELEMETRY

      Journal of cardiovascular pharmacology
    68. NAGURA J; HUI C; YAMAMOTO M; YASUDA S; ABE M; HACHISU M; KONNO F
      ME3221, A SURMOUNTABLE ANGIOTENSIN AT(1)-RECEPTOR ANTAGONIST, PREVENTS HYPERTENSIVE COMPLICATIONS IN AGED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Japanese Journal of Pharmacology
    69. POLIDORI C; CICCOCIOPPO R; POMPEI P; CIRILLO R; MASSI M
      FUNCTIONAL EVIDENCE FOR THE ABILITY OF ANGIOTENSIN AT(1) RECEPTOR ANTAGONISTS TO CROSS THE BLOOD-BRAIN-BARRIER IN RATS

      European journal of pharmacology
    70. FORHEAD AJ; WHYBREW K; HUGHES P; PIPKIN FB; SUTHERLAND M; FOWDEN AL
      COMPARISON OF ANGIOTENSIN-II TYPE-1 RECEPTOR BLOCKADE AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN PREGNANT SHEEP DURING LATE-GESTATION

      British Journal of Pharmacology
    71. HILDITCH A; PRIOR HM; DREW GM
      FURTHER INVESTIGATIONS INTO THE MECHANISM OF THE ANTIHYPERTENSIVE ACTIVITY OF THE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST, GR138950

      British Journal of Pharmacology
    72. ROWLAND NE; MORIEN A; FREGLY MJ
      LOSARTAN INHIBITION OF ANGIOTENSIN-RELATED DRINKING AND FOS IMMUNOREACTIVITY IN HYPERTENSIVE AND HYPOTENSIVE CONTEXTS

      Brain research
    73. RENZETTI AR; CRISCUOLI M; SALIMBENI A; SUBISSI A
      MOLECULAR PHARMACOLOGY OF LR-B 081, A NEW NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST/

      European journal of pharmacology. Molecular pharmacology section
    74. HARA M; KIYAMA R; NAKAJIMA S; KAWABATA T; KAWAKAMI M; OHTANI K; ITAZAKI K; FUJISHITA T; FUJIMOTO M
      KINETIC-STUDIES ON THE INTERACTION OF NONLABELED ANTAGONISTS WITH THEANGIOTENSIN-II RECEPTOR

      European journal of pharmacology. Molecular pharmacology section
    75. AMANO H; FUJIMOTO K; SUZUKI T; FUJII T; MOCHIZUKI S; TOMIYAMA A; KAWASHIMA K
      ANTIHYPERTENSIVE EFFECT OF CHRONIC KT3-671, A STRUCTURALLY NEW NONPEPTIDE ANGIOTENSIN AT(1)-RECEPTOR ANTAGONIST, IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Japanese Journal of Pharmacology
    76. CHOW L; DEGASPARO M; LEVENS N
      IMPROVED GLUCOSE-METABOLISM FOLLOWING BLOCKADE OF ANGIOTENSIN-CONVERTING ENZYME BUT NOT ANGIOTENSIN AT(1) RECEPTORS

      European journal of pharmacology
    77. CLARK KL; ROBERTSON MJ; DREW GM
      RENAL PHARMACOLOGY OF GR138950, A NOVEL NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST

      European journal of pharmacology
    78. POLIDORI C; CICCOCIOPPO R; POMPEI P; CIRILLO R; MASSI M
      THE SELECTIVE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST LR-B 081 POTENTLYINHIBITS DRINKING INDUCED BY CENTRAL INJECTION OF ANGIOTENSIN-II IN RATS/

      European journal of pharmacology
    79. HANCOCK AA; SURBER BW; ROTERT G; THOMAS S; TASKER AS; SORENSEN BK; VODENLICH AD; OPGENORTH TJ; KERKMAN DJ; DEBERNARDIS JF
      [H-3] A-81988, A POTENT, SELECTIVE, COMPETITIVE ANTAGONIST RADIOLIGAND FOR ANGIOTENSIN AT(1) RECEPTORS

      European journal of pharmacology. Molecular pharmacology section
    80. LACOUR C; CANALS F; GALINDO G; CAZAUBON C; SEGONDY D; NISATO D
      EFFICACY OF SR-47436 (BMS-186295), A NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST IN HYPERTENSIVE RAT MODELS

      European journal of pharmacology
    81. FENG CJ; CHENG DY; KAYE AD; KADOWITZ PJ; NOSSAMAN BD
      INFLUENCE OF N-OMEGA-NITRO-L-ARGININE METHYL-ESTER, LY83583, GLYBENCLAMIDE AND L158809 ON PULMONARY CIRCULATION

      European journal of pharmacology
    82. CHENG DY; DEWITT BJ; DENT EL; NOSSAMAN BD; KADOWITZ PJ
      ANALYSIS OF RESPONSES TO ANGIOTENSIN-IV IN THE PULMONARY VASCULAR BEDOF THE CAT

      European journal of pharmacology
    83. HILDITCH A; HUNT AAE; GARDNER CJ; TWISSELL DJ; POLLEY J; TRAVERS A; DREW GM; MIDDLEMISS D; ROSS BC; ROBERTSON MJ
      CARDIOVASCULAR EFFECTS OF GR117289, A NOVEL ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST

      British Journal of Pharmacology
    84. ROCCON A; MARCHIONNI D; DONAT F; SEGONDY D; CAZAUBON C; NISATO D
      A PHARMACODYNAMIC STUDY OF SR-47436, A SELECTIVE AT(1) RECEPTOR ANTAGONIST, ON BLOOD-PRESSURE IN CONSCIOUS CYNOMOLGUS MONKEYS

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:43:08